We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
-17.67%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$48.8B
AUM Growth
-$6.15B
Cap. Flow
+$12.8B
Cap. Flow %
26.19%
Top 10 Hldgs %
20.68%
Holding
4,585
New
132
Increased
2,502
Reduced
1,291
Closed
257

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$115M
2
IYF icon
iShares US Financials ETF
IYF
+$109M
3
V icon
Visa
V
+$108M
4
CHTR icon
Charter Communications
CHTR
+$73.8M
5
HON icon
Honeywell
HON
+$58.5M

Sector Composition

Rank Sector Weight
1 Technology 10.66%
2 Healthcare 6.66%
3 Financials 5.71%
4 Consumer Discretionary 5.02%
5 Communication Services 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABUS icon
4076
Arbutus Biopharma
ABUS
$906M
$71 ﹤0.01%
70
QHC
4077
DELISTED
Quorum Health Corporation
QHC
$71 ﹤0.01%
157
VRDN icon
4078
Viridian Therapeutics
VRDN
$2.49B
$69 ﹤0.01%
10
LRMR icon
4079
Larimar Therapeutics
LRMR
$444M
$67 ﹤0.01%
7
TBHC
4080
DELISTED
The Brand House Collective
TBHC
$66 ﹤0.01%
85
FCEL icon
4081
FuelCell Energy
FCEL
$1.63B
$62 ﹤0.01%
1
HBIO icon
4082
Harvard Bioscience
HBIO
$30.4M
$62 ﹤0.01%
3
ALNA
4083
DELISTED
Allena Pharmaceuticals
ALNA
$60 ﹤0.01%
62
COGT icon
4084
Cogent Biosciences
COGT
$6.47B
$58 ﹤0.01%
35
MARK
4085
DELISTED
Remark Holdings, Inc.
MARK
$58 ﹤0.01%
15
NMTR
4086
DELISTED
9 Meters Biopharma
NMTR
$55 ﹤0.01%
6
CRIS icon
4087
Curis
CRIS
$3.91M
0
ELGX
4088
DELISTED
Endologix Inc
ELGX
$53 ﹤0.01%
77
KOPN icon
4089
Kopin
KOPN
$898M
$50 ﹤0.01%
144
ZOM
4090
DELISTED
Zomedica Corp.
ZOM
$43 ﹤0.01%
225
SNDA icon
4091
Sonida Senior Living
SNDA
$1.88B
$42 ﹤0.01%
5
-20
-80% -$683
LBY
4092
DELISTED
Libbey, Inc.
LBY
$41 ﹤0.01%
81
-1
-1% -$1
BGFV
4093
DELISTED
Big 5 Sporting Goods
BGFV
$40 ﹤0.01%
37
CLDX icon
4094
Celldex Therapeutics
CLDX
$3.35B
$40 ﹤0.01%
24
TLGT
4095
DELISTED
Teligent, Inc
TLGT
$39 ﹤0.01%
14
TDW.WS.A
4096
DELISTED
Tidewater Inc. Series A Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.A
$35 ﹤0.01%
39
DSGX icon
4097
Descartes Systems
DSGX
$6.62B
$34 ﹤0.01%
+1
New +$42
LYTS icon
4098
LSI Industries
LYTS
$912M
$34 ﹤0.01%
9
-79
-90% -$453
CYBE
4099
DELISTED
Cyberoptics Corp
CYBE
$34 ﹤0.01%
2
MBCN
4100
DELISTED
Middlefield Banc Corp
MBCN
$32 ﹤0.01%
2

Similar funds

BNP Paribas Financial Markets's Q1 2020 Portfolio in Review

As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.

  • BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
  • BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
  • BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
  • BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
  • BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
  • BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
  • BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.